Faculty profile

Kim Connelly

ResearcherMedicine/NephrologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Kim Connelly

Researcher

Medicine/Nephrology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
17 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2026.
Supervised 2 trainees who won CIHR awards, most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

264

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Extracellular Matrix Acetazolamide Albuminuria Chronic Kidney Disease Glomerular Filtration Rate Sglt2 Inhibitor Type 2 Diabetes Cell Signalling

Latest papers

Machine Learning Reveals How Depression Influences Chest Pain Localisation and Its Predictive Value for Coronary Artery Disease.
The Canadian journal of cardiology · 2026
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1A.
CJC open · 2025
Practical Implications of Obesity for Cardiovascular Diagnostics.
The Canadian journal of cardiology · 2025 · senior author

All 41 publications

Latest funding

Adding AcetazolamIde on top of SGLT2 inhibition in Type 2 Diabetes and Albuminuria ('DIPPER') Study
CIHR · 2026 · Principal investigator
$761,176
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2025 · Co-investigator
$1,487,925
The systematic review of cardiovascular outcomes in major clinical heart failure trials by intersectionality of sex and gender, race, and age: Maximizing knowledge translation opportunities
CIHR · 2025 · Co-investigator
$183,600

All 25 grants and awards

41 publications.

Machine Learning Reveals How Depression Influences Chest Pain Localisation and Its Predictive Value for Coronary Artery Disease.

Malik MI, Lou W, Bisleri G, Connelly K, Bhat V

The Canadian journal of cardiology2026

DOI: 10.1016/j.cjca.2025.09.017 PMID: 40972896

The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1A.

Mielniczuk LM, O'Meara E, Wiefels C, Chen L, Garrard L, White J, deKemp RA, Di Carli MF, Larose E, Paterson DI, Ezekowitz J, Kandolin RM, Wright G, Campisi R, Laine MK, Connelly K, Rajda M, Vitola JV, Lepage S, Hartikainen J, Chow B, Tavoosi A, Knuuti J, Wells GA, Beanlands RSB, IMAGE HF Investigators

CJC open2025

DOI: 10.1016/j.cjco.2025.06.023 PMID: 41425785

Practical Implications of Obesity for Cardiovascular Diagnostics.

Poirier P, Lavie CJ, Connelly K

The Canadian journal of cardiology2025Senior author

DOI: 10.1016/j.cjca.2025.07.006 PMID: 40659314

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.

Punithan A, Ghamarian E, Grothe D, MacLean M, Connelly K, Neal B, Weisman A, Cherney DZI, Billia F, Udell JA

JACC. Advances2025

DOI: 10.1016/j.jacadv.2025.102276 PMID: 41151250

Unravelling Sex-Specific Differences in Early Cardiac Remodelling and Implications for Cardiovascular Risk.

Randhawa VK, Connelly K, Banks L

The Canadian journal of cardiology2025

DOI: 10.1016/j.cjca.2025.04.019 PMID: 40311674

Prevalence of Orthostatic Autonomic Dysregulation in Pediatric Concussion.

Sicard V, Irani T, Ledoux AA, Terekhov I, Webster RJ, Sucha E, Kutcher SA, Duan LX, Dashti F, Cortel-Leblanc A, Leddy J, Richer L, Reed N, Connelly K, Anderson C, Johnston S, Zemek R, uOttawa Brain-Heart Interconnectome (BHI) and TRANSCENDENT Concussion Integrated Discovery Programs

JAMA network open2025

DOI: 10.1001/jamanetworkopen.2025.22309 PMID: 40694349

Evaluating a novel accelerated free-breathing late gadolinium enhancement imaging sequence for assessment of myocardial injury.

Bhatt N, Orbach A, Biswas L, Strauss BH, Connelly K, Ghugre NR, Wright GA, Roifman I

Magnetic resonance imaging2024

DOI: 10.1016/j.mri.2024.01.020 PMID: 38309379

Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics.

Kosiborod MN, Cherney D, Connelly K, Desai AS, Guimarães PO, Kuthi L, Lala A, Madrini V, Merkely B, Villota JN, Squire I, Testani JM, Vaclavik J, Verma S, Wranicz J, Dahl M, Eudicone JM, Friberg L, Petrie MC

JACC. Heart failure2024

DOI: 10.1016/j.jchf.2024.05.003 PMID: 38878009

Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial.

Rajagopalan S, Dobre M, Dazard JE, Vergara-Martel A, Connelly K, Farkouh ME, Gaztanaga J, Conger H, Dever A, Razavi-Nematollahi L, Fares A, Pereira G, Edwards-Glenn J, Cameron M, Cameron C, Al-Kindi S, Brook RD, Pitt B, Weir M

Circulation2024

DOI: 10.1161/circulationaha.123.067620 PMID: 39129649

Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site.

Neves MAD, Ni TT, Mackeigan DT, Shoara AA, Lei X, Slavkovic S, Yu SY, Stratton TW, Gallant RC, Zhang D, Xu XR, Fernandes C, Zhu G, Hu X, Chazot N, Donaldson LW, Johnson PE, Connelly K, Rand M, Wang Y, Ni H

Research and practice in thrombosis and haemostasis2024

DOI: 10.1016/j.rpth.2024.102443 PMID: 38993621

Something wrong or missing on this profile? Suggest a correction

Kim Connelly

Research

Latest papers

Latest funding

Machine Learning Reveals How Depression Influences Chest Pain Localisation and Its Predictive Value for Coronary Artery Disease.

The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1A.

Practical Implications of Obesity for Cardiovascular Diagnostics.

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.

Unravelling Sex-Specific Differences in Early Cardiac Remodelling and Implications for Cardiovascular Risk.

Prevalence of Orthostatic Autonomic Dysregulation in Pediatric Concussion.

Evaluating a novel accelerated free-breathing late gadolinium enhancement imaging sequence for assessment of myocardial injury.

Sodium Zirconium Cyclosilicate in HFrEF&#xa0;and Hyperkalemia: REALIZE-K Design and Baseline Characteristics.

Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial.

Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site.

Frequent collaborators

Paul Poirier

Eric Larose

Howard Leong-Poi

Eva Lonn

Benjamin Chow

Anish Kirpalani

Paul Dorian

Laura Banks

Graham Wright

Koon Teo

Marc Ruel

Michael Farkouh

Petros Pechlivanoglou

Anne Fournier

James White

Louise Sun

Laura Banks

Sharon Johnston

Venkat Bhat

Mohammad Qadura

Alanna Weisman

Lawrence Richer

Yiming Wang

Andrew Pipe

Nick Reed

Claude Tousignant

Justin Ezekowitz

Filio Billia

David Cherney

Richard Whitlock

Andrew McRae

Sanjit Jolly

Michael Tsang

Nicholas Valettas

Kevin Teoh

Roger Zemek

Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics.